MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?

    C. Fox (Tucson, AZ, USA)

  • CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

    E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)

  • Cultural disparities in deep brain stimulation (DBS) decision making in patients with Parkinson’s disease (PD): Updates

    R. Shirane, M. Nisson, E. Moran, V. Shanker, C. Palmese (New York, NY, USA)

  • Customizing Rehabilitation based on oromotor function assessed with dynamic MRI in early Parkinson’s disease

    S.G Gudwani, K.S Sharma, P.U Upadhyay, S.K Kumaran, R.S Sagar, R.D Dhamija (New Delhi, India)

  • CVT-301 treatment provides consistent and clinically significant improvements in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) over 12 weeks

    A. Ellenbogen, A. Corbin, P. Zhao, D. Kegler-Ebo, H. Roberts (Bingham Farms, MI, USA)

  • Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases

    D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)

  • Daily Time-Course of Efficacy of Continuous Subcutaneous Infusion of Foslevodopa/foscarbidopa in Advanced Parkinson’s Disease Patients from a Phase 1b Study

    S. Stodtmann, M. Rosebraugh, W. Robieson, M. Facheris (North Chicago, IL, USA)

  • De novo impulse control disorder after globus pallidus internus deep brain stimulation in a patient with myoclonus-dystonia syndrome

    S. Parreira, L. Kauppila, M. Coelho (Lisboa, Portugal)

  • De-novo ß-actin mutation as a cause of seemingly sporadic dystonia-deafness syndrome responsive to deep-brain stimulation

    N. Schell, J.K Krauss, A. Saryyeva, C. Klein, N. Brüggemann (Luebeck, Germany)

  • Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD

    S. Kannenberg, L. Dinkelbach, J. Caspers, A. Moldovan, S. Ferrea, M. Südmeyer, M. Butz, A. Schnitzler, C. Hartmann (Düsseldorf, Germany)

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley